Pfizer, NCPA Agree Therapeutic Substitution Should Not Be Part Of Medicare

Pfizer and the National Community Pharmacists Association believe therapeutic substitution is not among the pharmacist care services that should be reimbursed under a Medicare prescription drug benefit.